Trending...
- Los Angeles County to Begin Distributing Vote by Mail Ballots to Registered Voters in Long Beach Beginning April 30 - 123
- CX Network Releases Report on the Best AI Support Tools for SaaS Companies 2026
- As Trump destroys the planet and green jobs, Governor Newsom announces California joins world's largest environmental protection organization
A plate-based fluorometric assay designed to screen, study and characterize potential inhibitors of CD38 hydrolase activity.
MILPITAS, Calif. - Californer -- Cluster of differentiation 38 (CD38), also known as cyclic ADP ribose hydrolase is a type II transmembrane glycoprotein that can function either as a receptor or as an enzyme. It is found on the surface of many immune cells, including plasma B cells, natural killer cells, CD4+, CD8+ etc. It is a multifunctional enzyme involved in cell-adhesion, calcium signaling and Nicotinamide Adenine Dinucleotide (NAD+) metabolism. The hydrolase activity of CD38 helps maintain the appropriate levels of NAD+ for all NAD+ dependent metabolic processes to occur. Elevated levels of CD38 are associated with aging, obesity, diabetes, heart disease, asthma, inflammation and tumorigenesis etc.
More on The Californer
BioVision's CD38 (Hydrolase) Inhibitor Screening Kit is a plate-based fluorometric assay designed to screen, study and characterize potential inhibitors of CD38 hydrolase activity. The assay utilizes a selective CD38 substrate to generate a fluorescent signal measured at Ex/Em = 300/410 nm. In the presence of potential CD38 hydrolase inhibitors, the fluorescent signal is reduced. The assay is quick, easy, and sensitive for high-throughput screening of CD38 inhibitors. Additionally, the kit includes a CD38 Inhibitor as a control inhibitor.
Figure: Inhibition of CD38 activity by Apigenin. IC50 was calculated to be 6.1 ± 0.1 μM. Assay was performed following the kit protocol.
For more information on this Assay Kit Cat# K2086, Visit: https://bit.ly/3ofloCb
More on The Californer
- Rio Vista Hosts Season of Free Music on Main Street: June Thur October Main Street Concert Series Kicks Off Summer w/ Community-Focused Entertainment
- California: Governor Newsom visits Pasadena City College construction trades lab helping LA rebuild
- City of Long Beach Deploys First-Ever Zero-Emissions Collections Trucks in New Pilot Program
- California: Governor Newsom celebrates launch of western regional energy market, designed to deliver lower energy costs and strengthen electric grid
- 1,000 Kids in Santa Clara County Need a Hero — This Race Is How Silicon Valley Answers the Call
BioVision's CD38 (Hydrolase) Inhibitor Screening Kit is a plate-based fluorometric assay designed to screen, study and characterize potential inhibitors of CD38 hydrolase activity. The assay utilizes a selective CD38 substrate to generate a fluorescent signal measured at Ex/Em = 300/410 nm. In the presence of potential CD38 hydrolase inhibitors, the fluorescent signal is reduced. The assay is quick, easy, and sensitive for high-throughput screening of CD38 inhibitors. Additionally, the kit includes a CD38 Inhibitor as a control inhibitor.
Figure: Inhibition of CD38 activity by Apigenin. IC50 was calculated to be 6.1 ± 0.1 μM. Assay was performed following the kit protocol.
For more information on this Assay Kit Cat# K2086, Visit: https://bit.ly/3ofloCb
Source: BioVision, Inc.
Filed Under: Biotech
0 Comments
Latest on The Californer
- Scott Ritsema of Bisnar Chase Selected for 2026 National Traumatic Brain Injury Association
- Datacate Launches Free IT Asset Disposition (ITAD) Services for Secure Hardware Disposal
- Flint Youth Film Festival Shifts Gears, Becomes Vehicle City Film Festival
- USA Corp Releases The LK-99 Material Constitution: Room-Temperature Superconductivity Specs
- 62% of Gen X have no estate planning documents — Trust & Will research identifies "the Sandwich Gap"
- Nayarit's Jungle Coast Redefines Luxury Travel on Mexico's Pacific Now More Accessible Than Ever
- Coachella Valley Innovation Alliance Launches New 9-City Regional Innovation Platform
- Gabriel Vega Launches Weekly Mortgage and Real Estate Newsletter for Inland Empire Clients
- RUNWAY® Magazine Launches Official Merchandise Collection Amid Devil Wears Prada 2 release
- $10 Million Annual Revenue Merger, Profitable Partner in AI Powered Specialty Automotive Sales Projected to Scale Above $200M: Stock Symbol: NWPG
- Virginia Moving Company Nearly Doubles Customer Calls in Two Weeks After Switching to CARL — the Bold New Alternative to WordPress
- eRacks Expands Rackmount NAS Lineup to 11 Models, 4 Bays to 100 Bays, From $1,995
- Best AI Consulting Service for Small Businesses in Los Angeles-Daizy Chain Launches Easiest Way to
- Memories Unleashed at North Coast Rep Variety Nights
- Cat Rodriguez Launches Second Season Golf, Redefining Vintage and Secondhand Golf Apparel for Women
- For Small Business Week: This Math should be Required Reading For Every Business in the Universe!
- RAS AP Consulting Launches Vendor Master File & Payment Controls Assessment for NACHA Phase 2 Compliance
- Your Email List Is a Revenue Engine You Haven't Turned On Yet
- Campus Bookstores at the Ventura County Community College District Now Accepting CalFresh Benefits
- City Announces Grand Marshals for 2026 Long Beach Pride Parade